Patrick Kelly

8.7k citations

92 papers · 6.0k indexed · 3 hit papers · h-index 36

Impact in

Genetics top 0.5%
- BRCA gene mutations in cancer
- Virus-based gene therapy research
- Chronic Lymphocytic Leukemia Research
Cancer Research top 2%
- Cancer Genomics and Diagnostics

Papers in

Genetics 26
- Virus-based gene therapy research 14
- Chronic Lymphocytic Leukemia Research 13
- Hemoglobinopathies and Related Disorders 8
Hematology 16
- Acute Myeloid Leukemia Research 7

Co-authors: Patrick J. Casey Nazneen Rahman Sheila Seal Douglas F. Easton Tasnim Chagtai Diana Eccles D. Gareth Evans Rita Barfoot
Journals: Blood (23 papers)Journal of Biological Chemistry (7 papers)Journal of Clinical Oncology (7 papers)Human Gene Therapy (5 papers)Molecular Therapy (4 papers)
Partner nations: United States Australia United Kingdom

In The Last Decade

Patrick Kelly

91 papers receiving 5.8k citations

Hit Papers

align trajectories log scale

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene 2006 · 689 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2006 Nature Genetics
2006 Nature Genetics
2006 Nature Genetics

Peers

Countries citing papers authored by Patrick Kelly

Since Specialization

Citations

This map shows the geographic impact of Patrick Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Kelly more than expected).

Fields of papers citing papers by Patrick Kelly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Kelly. The network helps show where Patrick Kelly may publish in the future.

Co-authors

The 25 scholars most cited alongside Patrick Kelly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick Kelly Line = papers co-authored together Patrick Kelly links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Feedback between F-actin organization and active stress governs criticality and energy localization in the cell cytoskeleton Nature Physics ·Chris Ingraham, 陽平幸本, Patrick Kelly, L. L., Garegin A. Papoian, Michael P. Murrell	2025	0
2	Multicenter, phase 1 study of etavopivat (FT-4202) treatment for up to 12 weeks in patients with sickle cell disease Blood Advances ·Santosh L. Saraf, Pallavi Priya Patharlagadda, Modupe Idowu, Ifeyinwa Osunkwo, M R Drauss, Frans A. Kuypers, R. Clark Brown, James Geib, Maria Ribadeneira, Patricia Schroeder, Eric Wu, Andreas Walz, Patrick Kelly, Theodosia A. Kalfa, Marilyn J. Telen	2024	7
3	FT-4202, an Allosteric Activator of Pyruvate Kinase-R, Demonstrates Proof of Mechanism and Proof of Concept after a Single Dose and after Multiple Daily Doses in a Phase 1 Study of Patients with Sickle Cell Disease Blood ·R. Clark Brown, M R Drauss, Theodosia A. Kalfa, Frans A. Kuypers, Santosh L. Saraf, Jeremie H. Estepp, Luke R. Smart, Punam Malik, Mark A. Lerman, Shirley G Rosen, Maria Ribadeneira, Andreas Walz, Patricia Schroeder, Eric Wu, Patrick Kelly, Marilyn J. Telen	2020	14
4	FT-2102, an IDH1m Inhibitor, in Combination with Azacitidine in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Ayndrome (MDS): Results from a Phase 1 Study Blood ·Jörge E. Cortes, Justin M. Watts, Thomas Prébet, Gary J. Schiller, Sang‐Min Lee, Jay Yang, Eunice S. Wang, Shira Dinner, P. Brent Ferrell, Will Donnellan, Brian A. Jonas, Andrew H. Wei, Pau Montesinos, Metha Anung Anindhita, Patrick Kelly, Ping Li, Jennifer Sweeney, Courtney Watson, Hesham Mohamed, Maria R. Baer	2018	14
5	Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies Blood ·Ian W. Flinn, Susan O’Brien, Brad S. Kahl, Manish R. Patel, Yasuhiro Oki, Mauro Emilio, Pierluigi Porcu, Jeffrey A. Jones, Jan A. Burger, Nitin Jain, Virginia Kelly, Kerstin Allen, Mark Douglas, Jennifer Sweeney, Patrick Kelly, Steven M. Horwitz	2017	183
6	Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma Blood ·Steven M. Horwitz, Raphael Koch, Pierluigi Porcu, Yasuhiro Oki, Alison J. Moskowitz, Megan N. Perez, Patricia L. Myskowski, Adam Officer, Jacob D. Jaffe, Sara Morrow, Kerstin Allen, Mark Douglas, Howard M. Stern, Jennifer Sweeney, Patrick Kelly, Virginia Kelly, Jon C. Aster, David T. Weaver, Francine M. Foss, David M. Weinstock	2017	204
7	Activation of Rap1 Promotes Prostate Cancer Metastasis Cancer Research ·Candice L. Bailey, Patrick Kelly, Patrick J. Casey	2009	119
8	Biallelic mutations in PALB2 cause Fanconi anemia and predispose to childhood cancer Cancer Research ·Sarah Reid, Detlev Schindler, Helmut Hanenberg, Marc Tischkowitz, Sandra Hanks, Karen Barker, Patrick Kelly, Sheila Seal, Sat Dev Batish, Francis P. Lach, Reinhard Kalb, Kornelia Neveling, Christopher G. Mathew, Arleen D. Auerbach, Nazneen Rahman	2007	1
9	Importance of Murine Study Design for Testing Toxicity of Retroviral Vectors in Support of Phase I Trials Molecular Therapy ·Elke Will, Jeff Bailey, Gao Shang-Wei, Ute Modlich, Brenden Balcik, J J Wang, David P. Witte, Gerlinde Layh‐Schmitt, Cornelia Rudolph, Brigitte Schlegelberger, Christof von Kalle, Christopher Baum, Brian P. Sorrentino, Lars M. Wagner, Patrick Kelly, Lilith Reeves, David A. Williams	2007	20
10	A Role for the G12 Family of Heterotrimeric G Proteins in Prostate Cancer Invasion Journal of Biological Chemistry ·Patrick Kelly, M. R. Klauber, John F. Madden, Timothy A. Fields, Yehia Daaka, Patrick J. Casey	2006	123
11	PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene Nature Genetics ·Nazneen Rahman, Sheila Seal, Deborah J. Thompson, Patrick Kelly, Anthony Renwick, Anna Elliott, Sarah Reid, Ciliana Oliveira Pinheira, Rita Barfoot, Tasnim Chagtai, Hiran Jayatilake, Lesley McGuffog, Sandra Hanks, D. Gareth Evans, Diana Eccles, Douglas F. Easton, Michael R. Stratton Hit paper breakdown →	2006	689
12	ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles Nature Genetics ·Anthony Renwick, Deborah J. Thompson, Sheila Seal, Patrick Kelly, Tasnim Chagtai, Munaza Ahmed, Bernard V. North, Hiran Jayatilake, Rita Barfoot, Ciliana Oliveira Pinheira, Lesley McGuffog, D. Gareth Evans, Diana Eccles, Douglas F. Easton, Michael R. Stratton, Nazneen Rahman Hit paper breakdown →	2006	511
13	Chemotherapy for myeloid malignancy in children with Fanconi anemia Pediatric Blood & Cancer ·Parinda A. Mehta, Talia İleri, Richard E. Harris, David A. Williams, Jun Mo, Teresa A. Smolarek, Arleen D. Auerbach, Patrick Kelly, Stella M. Davies	2006	36
14	Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles Nature Genetics ·Sheila Seal, Deborah J. Thompson, Anthony Renwick, Anna Elliott, Patrick Kelly, Rita Barfoot, Tasnim Chagtai, Hiran Jayatilake, Munaza Ahmed, Ciliana Oliveira Pinheira, Bernard V. North, Lesley McGuffog, D. Gareth Evans, Diana Eccles, Douglas F. Easton, Michael R. Stratton, Nazneen Rahman Hit paper breakdown →	2006	513
15	The type III TGF-β receptor suppresses breast cancer progression Journal of Clinical Investigation ·Mei Dong, Tam How, Kellye C. Kirkbride, Kelly J. Gordon, Jason D. Lee, Nadine Hempel, Patrick Kelly, Benjamin J. Moeller, Jeffrey R. Marks, Gerard C. Blobe	2006	204
16	Stem cell clonality and genotoxicity in hematopoietic cells: Gene activation side effects should be avoidable Seminars in Hematology ·Christof von Kalle, Boris Fehse, Gerlinde Layh‐Schmitt, Manfred Schmidt, Patrick Kelly, Christel Baum	2004	29
17	Direct comparison of RD114-pseudotyped versus amphotropic-pseudotyped retroviral vectors for transduction of rhesus macaque long-term repopulating cells Molecular Therapy ·Jiong Hu, Patrick Kelly, Aylin Bonifacino, Brian Agricola, Robert E. Donahue, Elio F. Vanin, Cynthia E. Dunbar	2003	13
18	Treatment of children with Langerhans cell histiocytosis with 2‐chlorodeoxyadenosine American Journal of Hematology ·Carlos Rodríguez‐Galindo, Patrick Kelly, Michael Jeng, W. Bekerman, Elysa Rois. Palupi, Winfred C. Wang	2002	32
19	Human Cord Blood CD34+CD38- Cell Transduction via Lentivirus-Based Gene Transfer Vectors Human Gene Therapy ·Jay T. Evans, Patrick Kelly, Eduardo O’Neill, J. Victor Garcia	1999	71
20	High-Efficiency Transduction and Long-Term Gene Expression with a Murine Stem Cell Retroviral Vector Encoding the Green Fluorescent Protein in Human Marrow Stromal Cells Human Gene Therapy ·J Jerlin Ida, James A. Allay, Derek A. Persons, Christine Billings, Phillip W. Hargrove, Patrick Kelly, Elio F. Vanin, Edwin M. Horwitz	1999	98

About Patrick Kelly

Patrick Kelly is a scholar working on Genetics, Hematology, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 92 papers that have together received 6.0k indexed citations. Recurring topics across this work include Virus-based gene therapy research (14 papers), Chronic Lymphocytic Leukemia Research (13 papers), CRISPR and Genetic Engineering (13 papers), DNA Repair Mechanisms (9 papers), RNA Interference and Gene Delivery (9 papers), Lymphoma Diagnosis and Treatment (9 papers), Hemoglobinopathies and Related Disorders (8 papers) and Acute Myeloid Leukemia Research (7 papers). The work is most often cited by research in Genetics (2.3k citations), Genetics (796 citations), Cancer Research (988 citations), Pathology and Forensic Medicine (1.0k citations) and Molecular Biology (3.8k citations). Patrick Kelly has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Patrick J. Casey, Nazneen Rahman, Sheila Seal, Douglas F. Easton, Tasnim Chagtai, Diana Eccles, D. Gareth Evans, Rita Barfoot, Lesley McGuffog and Hiran Jayatilake. Their work appears in journals such as Blood, Journal of Biological Chemistry, Journal of Clinical Oncology, Human Gene Therapy and Molecular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact